Alan Nurden: From Early Discoveries to New Therapeutic Advances in von Willebrand Disease
Alan Nurden, Emeritus Research Director at CNRS, Co-Founder of the French National Reference Centre for Inherited Platelet Disorders (CRPP), shared a post on LinkedIn about a recent article by Caterina Casari et al, published in Haematologica:
“This is an excellent review of von Willebrand disease and its therapeutic landscape by three respected experts. It begins with the history of early discoveries and ends with an assessment of the range of new therapeutic advances that offer much hope for a sustainable prophylaxis that will greatly enhance the quality of life of patients.
For me, it is good to see highlighted such pioneers as Judith Poole (Stanford Univ, USA), Theodore Zimmerman (Scripps Clinic, USA), Birger and Margareta Blomback (Karolinska Institute, Sweden), Pïer Mannuccio Mannucci (Milan, Italy) happily still active, and the sadly missed J Evan Saddler (St. Louis, USA); and which extends through to a new generation such as Cécile Denis and Peter Lenting from France to name but two.
This review is highly recommended.”
Title: Historical, current and future treatments for von Willebrand disease
Authors: Caterina Casari, Frank W.G. Leebeek, Flora Peyvandi
Read the Full Article on Haematologica.
Other articles featuring Alan Nurden on Hemostasis Today.
-
Jun 7, 2026, 12:01Addressing Real-World Challenges in Thrombosis Care Through Case-Based Learning – Thrombosis Canada
-
Jun 7, 2026, 11:46Zehraan Ibni Akbar: Transforming Laboratory Data into Clinical Decisions Through Platelet Disorder Recognition
-
Jun 7, 2026, 11:31Alice Zerbinati: Y-90 Radioembolization Expands Curative Options for Advanced Hepatocellular Carcinoma
-
Jun 7, 2026, 09:26Filimon Dagnew Bezabih: SNMMI Honors 18F-GP1 PET Imaging for Innovation in Thrombosis Detection
-
Jun 7, 2026, 06:57Chandran Nadarajan: Targeted Endovascular Thrombolysis Offers Organ-Saving Benefits in Vascular Occlusions
-
Jun 7, 2026, 05:50Sayan Koley: Lupus Anticoagulant – A Key Marker in Thrombosis Risk Assessment
-
Jun 7, 2026, 05:45Nicolas Hubacz: Watching a Heart Build Its Network
-
Jun 7, 2026, 05:40New Evidence Highlights the Urgent Need for Gender-Inclusive Bleeding Disorders Research – EHC
-
Jun 7, 2026, 03:15Shirley D’Sa: What Comes After BTK Inhibitors in Waldenström Macroglobulinaemia?